Sort
21,281 grants matching “influenza”
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,700,000Mark M Davis · Stanford University · P01 · FY2021 · AI
DEVELOPMENT OF VACCINES FOR INFLUENZA USING AN IMMUNO-MODULATOR ADJUVANT AND MULTI-PLATFORM APPROACH
$3,691,826Bruxanne El-Kammash · University Of Chicago · N01 · FY2024 · AI
Connecticut Emerging Infections Program
$3,672,698Matthew Lewis Cartter · Connecticut State Dept Of Public Health · U01 · FY2010 · CI
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,670,549Alan M Fogelman · University Of California Los Angeles · P01 · FY2006 · HL
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$3,668,794Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$3,667,392Emmanuel Walter · Duke University · N01 · FY2021 · AI
Influenza and Emerging Infectious Diseases
$3,655,513Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
COVID-19: Identification and Development of Clinical Candidates to Treat SARS-CoV-2
$3,643,319Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
A Nurse-Community Health Worker-Family Partnership Model to Increase COVID-19 Testing in Urban Underserved and Vulnerable Communities
$3,643,065Holly C. Hagan · New York University · P30 · FY2020 · DA
Cellular Immunity to Category A-C Viruses in Humans
$3,639,795Alan L Rothman · Univ Of Massachusetts Med Sch Worcester · U19 · FY2009 · AI
Advanced Development of Universal Vaccines for Universal Influenza
$3,608,426Christopher Locher · Versatope Therapeutics, Inc. · N01 · FY2024 · AI
Development/production of universal influenza vaccines
$3,607,128Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIB · FY2017 · AI
Novel Nanoparticle Platform for the delivery of Vaccines and Adjuvants
$3,603,126Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
ARRA: Animal Model Support of Universal Influenza Vaccine
$3,600,000Srinivas Rao · National Institute Of Allergy And Infectious Diseases · ZIG · FY2010 · AI
NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Universal Influenza Vaccine Research Activities
$3,599,265Scott Hensley · University Of Pennsylvania · N01 · FY2025 · AI
RFA-GH-19-004, Advancing Public Health Research in Bangladesh
$3,588,493Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2023 · GH
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,584,797University Of California Los Angeles · P01 · FY2005 · HL
Adjuvant development in the context of seasonal and pandemic influenza
$3,583,801Jay Evans · University Of Montana · N01 · FY2021 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$3,583,595Richard Rothman · Johns Hopkins University · N01 · FY2015 · AI
Tissue and organ specific human B cell immunity
$3,563,564Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2019 · AI
Tissue and organ specific human B cell immunity
$3,562,534Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2020 · AI
Tissue and organ specific human B cell immunity
$3,558,962Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2021 · AI
Tissue and organ specific human B cell immunity
$3,556,205Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2022 · AI
Alaska INBRE-2: Environmental Agents and Disease
$3,554,425Jocelyn E Krebs · University Of Alaska Fairbanks · P20 · FY2009 · RR
Tissue and organ specific human B cell immunity
$3,552,993Frances E. Lund · University Of Alabama At Birmingham · U19 · FY2023 · AI